MOLLY SHARP: Open Payments
NPI 1922257088 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,444 in 88 payments from 15 companies in 2025. Trend: 2023 $877 · 2024 $329 · 2025 $1,444
Food & beverage: $1,444
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 13 | $210 |
| ABBVIE INC. | 21 | $200 |
| Alkermes, Inc. | 10 | $180 |
| Supernus Pharmaceuticals, Inc. | 8 | $132 |
| Janssen Pharmaceuticals, Inc | 5 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| Vanda Pharmaceuticals Inc. | 5 | $92 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| Axsome Therapeutics, Inc. | 3 | $62 |
Products named: VRAYLAR, REXULTI, ARISTADA, Qelbree, CAPLYTA, COBENFY, SPRAVATO, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
